Optinose to Present at the Piper Sandler 36th Annual Healthcare Conference

OPTN 12.02.2024

SERA-AI Powered Highlights
Date of Upcoming Event:2024-12-05
Name of Upcoming Event:Piper Sandler 36th Annual Healthcare Conference
Full Press ReleaseSEC FilingsOur OPTN Tweets

About Gravity Analytica

Recent News

  • 01.15.2025 - Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
  • 12.26.2024 - Optinose Announces 1-for-15 Reverse Stock Split
  • 12.05.2024 - Piper Sandler 36th Annual Healthcare Conference

Recent Filings

  • 01.15.2025 - 8-K Current report
  • 01.15.2025 - EX-99.1 EX-99.1
  • 12.18.2024 - 4 Statement of changes in beneficial ownership of securities

YARDLEY, Pa.,Dec. 02, 2024(GLOBE NEWSWIRE) --Optinose(NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Piper Sandler 36th Annual Healthcare Conference onDecember 5, 2024at1:30 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of theOptinosewebsite.

A replay of the webcast will be available for 30 days following the conclusion of the event.

AboutOptinoseOptinoseis a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visitwww.optinose.comor follow us onXandLinkedIn.

Optinose Investor ContactJonathan Neelyjonathan.neely@optinose.com267.521.0531

Primary Logo

Source: Optinose, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com